- NTLA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Intellia Therapeutics (NTLA) 8-K10 Jan 25Intellia Therapeutics Announces Anticipated 2025 Milestones and Pipeline priorities result in NTLA-3001 discontinuation and select, research-focused investmentFinancial data
Company Profile